Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2021-07-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
特一药业关于与广州海博特医药科技有限公司签订战略合作协议及技术服务合同的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 特一药业集团股份有限公司 regarding the signing of a strategic cooperation agreement and a technical service contract with 广州海博特医药科技有限公司. It details the purpose, terms, and expected impact of the agreements, emphasizing that these agreements do not have a significant impact on the company's 2021 financial results. The document is structured as a formal announcement to shareholders and the public, including risk warnings and background information on the cooperation. It does not contain financial statements, audit opinions, or detailed financial data. It is not a report like an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a regulatory certification or a voting result announcement. The content fits the category of a general regulatory announcement about a corporate agreement and cooperation, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories. The document length is 4234 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-07-06 Chinese
2021年第二季度可转换公司债券转股情况公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of 特一药业集团股份有限公司 for the second quarter of 2021. It details the bond issuance, conversion price adjustments, and the changes in shareholding due to bond conversions during the quarter. The document includes regulatory references to the Shenzhen Stock Exchange and China Securities Regulatory Commission approvals. It is a formal disclosure of bond conversion and shareholding changes, not a full financial report or earnings release. The document length is 2538 characters, which is relatively short and focused on a specific capital market event. This fits the category of Capital/Financing Update (CAP), as it updates on convertible bond conversions and related share capital changes.
2021-07-01 Chinese
关于控股股东股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a controlling shareholder and provides detailed information about share pledges and related risks. It includes tables of shareholding and pledge status, explanations about the shareholders, and risk disclosures. There is no financial statement, earnings data, or management discussion of financial results. The document is a regulatory announcement about share pledge status and changes, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like shareholding notifications (MRQ) because it focuses on pledge release rather than ownership threshold changes, nor is it a capital change or share issue announcement. The document length is short (1975 characters), and it is not a report publication announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2021-06-18 Chinese
2017年特一药业集团股份有限公司可转换公司债券2021年跟踪评级报告
Regulatory Filings
2021-06-17 Chinese
关于可转换公司债券2021年跟踪评级报告的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement regarding the 2021 tracking credit rating report for a convertible bond issued in 2017 by the company. It references the credit rating agency's report and provides a link to the full report on an external website. The document is short (782 characters) and primarily serves to announce the issuance and availability of the rating report rather than containing the full report or detailed financial data itself. Therefore, it fits the criteria for a Report Publication Announcement (RPA) rather than the report itself or other categories like Capital/Financing Update (CAP).
2021-06-17 Chinese
关于控股股东进行股票质押的公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the proportion of shares pledged relative to total holdings and company capital, the purpose of the pledge, and the risk assessment related to the pledge. There is no financial statement, earnings data, or management discussion of financial results. The document is a regulatory announcement about a shareholder's share pledge transaction, which fits the category of Director's Dealing or similar. However, since it concerns a controlling shareholder's stock pledge (a form of share collateralization), it is best classified under Director's Dealing (DIRS), which covers personal share transactions by company directors and executives, including share pledges. The document length is short (2611 characters), and it is not a report publication announcement or certification. Therefore, the appropriate classification is DIRS with high confidence.
2021-06-14 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.